Functional Proteomics Identifies Targets of Phosphorylation by B-Raf Signaling in Melanoma

Abstract

SUMMARY Melanoma and other cancers harbor oncogenic mutations in the protein kinase B-Raf, which leads to constitutive activation and dysregulation of MAP kinase signaling. In order to elucidate molecular determinants responsible for B-Raf control of cancer phenotypes, we present a method for phosphoprotein profiling, using negative ionization mass spectrometry to detect phosphopeptides based on their fragment ion signature caused by release of PO3−. The method provides an alternative strategy for phosphoproteomics, circumventing affinity enrichment of phosphopeptides and isotopic labeling of samples. Ninety phosphorylation events were regulated by oncogenic B-Raf signaling, based on their responses to treating melanoma cells with MKK1/2 inhibitor. Regulated phosphoproteins included known signaling effectors and cytoskeletal regulators. We investigated MINERVA/FAM129B, a target belonging to a protein family with unknown category and function, and established the importance of this protein and its MAP kinase-dependent phosphorylation in controlling melanoma cell invasion into 3-dimensional collagen matrix.

The Role of Novel 3d-Copper Cyanide Supramolecular Coordination Polymer in Epithelial Mesenchymal Transition Inhibition in Hepatocellular Carcinoma

“…Thus, orchestrated inhibition of activated ERK may be a good therapeutic approach for targeting signaling cascades that underlie tumorgenesis. Our finding that overexpression of p-ERK1/2 up-regulated β-catenin protein levels is consistent with recent reports that ascribe subtype-specific functions to the two major ERK isoforms [37]. We speculated that overexpression of ERK in hepatocytes causes' hyperproliferative cell, leading to tumorigenicity.…”

Hsp90 phosphorylation, Wee1 and the cell cycle

“…27,35 Hsp90 is also a substrate for DNA-dependent protein kinase, Akt, B-Raf and casein kinase II (CKII). 36,37,40,41 Further, PKA phosphorylation of Thr90 induced by 3-hydroxy-3-methylglutarylcoenzyme A reductase inhibitors has been reported to increase association of human Hsp90α with the client protein eNOS. 42 Lastly, a study reported that protein phosphatase 5 (Pp5/Ppt1) can dephosphorylate Hsp90 in vitro.…”

Identification of Extracellular Signal-regulated Kinase 1 (ERK1) Direct Substrates using Stable Isotope Labeled Kinase Assay-Linked Phosphoproteomics

“…By comparing the control cell versus inhibitor treated cells, the ERK1 dependent phosphoproteins can be retrieved. Based on this approach, Mann's group identified 98 proteins with 167 phosphorylation sites using SILAC quantitation (41), whereas Ahn's group identified 35 proteins with 60 phosphorylation sites using label-free quantitation (42). In the same year, Hattori's group identified 38 proteins using 2D-DIGE, IMAC, and phosphomotif antibodies (43).…”